3.66 USD
↘ 0.12 (3.17%)AT CLOSE (11:59 AM EDT)
Rocket Pharmaceuticals, Inc. Common Stock
RCKTNASDAQ • USD
3.73
↗ 0.07 (1.91%)
POST MARKET (AS OF 07:59 PM EDT)
Post Market
AS OF 07:59 PM EDT
3.73
↗ 0.07 (1.91%)
Market: CLOSED
Rocket Pharmaceuticals, Inc. Common Stock (RCKT) trades at $3.66 per share. RCKT shows a split signal: technical indicators suggest "Strong Buy" while underlying fundamentals indicate "Sell". Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bearish Death Cross on the long-term moving averages. The stock looks compelling on valuation, with multiples below sector averages across P/E, P/B, and EV/EBITDA.
Technical & fundamental data as of Aug 26, 2026.
Open?$3.73
High?$3.73
Low?$3.58
Prev. Close?$3.78
Volume?1.1M
Avg. Volume?1.4M
VWAP?$3.63
Rel. Volume?0.78x
Bid / Ask
Bid?$3.66 × 2.0K
Ask?$3.73 × 1.0K
Spread?$0.07
Midpoint?$3.70
Valuation & Ratios
Market Cap?401.8M
Shares Out?109.8M
Float?84.6M
Float %?77.5%
P/E Ratio?N/A
P/B Ratio?1.09
EPS?-$0.16
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. It has one reportable segment related to R&D and commercial readiness of its gene therapies.
Themes
Employees
202
Market Cap
414.9M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2015-02-18
Address
350 FIFTH AVENUE
NEW YORK, NY 10118
Phone: 646-440-9100
NEW YORK, NY 10118
Phone: 646-440-9100
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+2/3)
Medium-Term (Wave)?▲ Bullish(+2/3)
Short-Term (Ripple)?▲ Bullish(+2/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?1
Momentum?65
Short Sent.?50
Piotroski F-Score?0/9Weak
Altman Z-Score?-0.69Distress
Confidence?54%Low
Short InterestHigh
Short % of Float?17.01%High
Short Interest?14.4M
Days to Cover?8.6
Free Float84.6M
Avg Daily Volume1.7M
Settlement Date2026-08-14
Financial Health
Current Ratio?9.24Strong
Quick Ratio?9.24Strong
Cash Ratio?7.17Strong
Debt/Equity?0.06Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score100/100
P/E?N/A▾
P/B?1.09CHEAP▾
Peers100
S&P97
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-1.1CHEAP▾
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-4.7%WEAK▾
S&P11
ROA?-4.1%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-170394000
Enterprise Value?$198.5M
Fundamentals ratios updated end of day